Collaborating with diverse stakeholders, including the FDA and the Surveillance, Epidemiology, and End Results program, CancerLinQ continues its efforts to harness big data to rapidly improve the quality of care for people with cancer.
Kevin Fitzpatrick
Advertisement
Articles by Kevin Fitzpatrick
Advertisement
Latest Updated Articles
- The Newest Members of CancerLinQ's Community—FDA and NCI
August 11th 2017
Advertisement
Advertisement
Trending on AJMC
1
COVID-19 May Follow a Different Seasonal Pattern Than Influenza, RSV
2
New Bill Would Cap Traditional Medicare Out-of-Pocket Costs at $5000
3
Topical Delgocitinib Improves Chronic Hand Eczema Outcomes Across All Trial Timepoints
4
FDA Expands Risankizumab Approval to Pediatric Plaque Psoriasis, Active PsA
5